{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:16:00Z","timestamp":1771478160869,"version":"3.50.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/hco.0b013e3283653f41","type":"journal-article","created":{"date-parts":[[2013,9,27]],"date-time":"2013-09-27T22:35:24Z","timestamp":1380321324000},"page":"676-682","source":"Crossref","is-referenced-by-count":21,"title":["Therapeutic strategies to prevent contrast-induced acute kidney injury"],"prefix":"10.1097","volume":"28","author":[{"given":"Cristina","family":"Quintavalle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Briguori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerolama","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s11886-010-0129-2","article-title":"Contrast-induced acute kidney injury: the at-risk patient and protective measures.","volume":"12","author":"Brown","year":"2010","journal-title":"Curr Cardiol Rep"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00134-003-2078-3","article-title":"Defining acute renal failure: physiological principles.","volume":"30","author":"Bellomo","year":"2004","journal-title":"Intensive Care Med"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1038\/sj.ki.5000375","article-title":"How to prevent contrast-induced nephropathy and manage risk patients: practical recommendations.","volume":"100","author":"Solomon","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury.","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/sj.ki.5000374","article-title":"Follow-up of patients with contrast-induced nephropathy.","volume":"100","author":"Solomon","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjcard.2007.10.051","article-title":"A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system.","volume":"101","author":"Harjai","year":"2008","journal-title":"Am J Cardiol"},{"key":"R8-12-20210204","first-page":"1097","article-title":"Clinical study of tubular creatinine secretion in renal dysfunction in Japanese.","volume":"33","author":"Hatano","year":"1991","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/ajkd.2002.34487","article-title":"Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.","volume":"40","author":"Dharnidharka","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1523-1755.2004.00861.x","article-title":"Early detection of acute renal failure by serum cystatin C.","volume":"66","author":"Herget-Rosenthal","year":"2004","journal-title":"Kidney Int"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2369-14-17","article-title":"Urine IL-18, NGAL IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation.","volume":"14","author":"Sirota","year":"2013","journal-title":"BMC Nephrol"},{"key":"R12-12-20210204","first-page":"F552","article-title":"Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.","volume":"286","author":"Ichimura","year":"2004","journal-title":"Am J Physiol"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","article-title":"Contrast-induced acute kidney injury.","volume":"51","author":"McCullough","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R14-12-20210204","first-page":"1393","article-title":"A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.","volume":"44","author":"Mehran","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198901193200303","article-title":"Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both.","volume":"320","author":"Parfrey","year":"1989","journal-title":"N Engl J Med"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9343(90)90180-L","article-title":"Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography.","volume":"89","author":"Manske","year":"1990","journal-title":"Am J Med"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJMoa021833","article-title":"Nephrotoxic effects in high-risk patients undergoing angiography.","volume":"348","author":"Aspelin","year":"2003","journal-title":"N Engl J Med"},{"key":"R18-12-20210204","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1038\/cddis.2011.38","article-title":"In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis.","volume":"2","author":"Quintavalle","year":"2011","journal-title":"Cell Death Dis"},{"key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1161\/CIRCULATIONAHA.112.103317","article-title":"Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury.","volume":"126","author":"Quintavalle","year":"2012","journal-title":"Circulation"},{"key":"R20-12-20210204","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehn197","article-title":"Contrast agents and renal cell apoptosis.","volume":"29","author":"Romano","year":"2008","journal-title":"Eur Heart J"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.","volume":"21","author":"Stacul","year":"2011","journal-title":"Eur Radiol"},{"key":"R22-12-20210204","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1148\/radiol.10091485","article-title":"Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat.","volume":"256","author":"Seeliger","year":"2010","journal-title":"Radiology"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"C29","DOI":"10.1159\/000066641","article-title":"A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity.","volume":"93","author":"Trivedi","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"R24-12-20210204","first-page":"1","article-title":"What is the best hydration regimen to prevent contrast media-induced nephrotoxicity Clin N","volume":"62","author":"Bader","year":"2004","journal-title":"ephrol"},{"key":"R25-12-20210204","first-page":"699","article-title":"Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study.","volume":"15","author":"Krasuski","year":"2003","journal-title":"J Invasive Cardiol"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.106.687152","article-title":"Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies.","volume":"115","author":"Briguori","year":"2007","journal-title":"Circulation"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2215\/CJN.03120509","article-title":"Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis.","volume":"4","author":"Brar","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-12-20210204","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(98)00574-9","article-title":"A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. study.","volume":"33","author":"Stevens","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ijcard.2011.11.035","article-title":"Feasibility study of the RenalGuard balanced hydration system: a novel strategy for the prevention of contrast-induced nephropathy in high risk patients.","volume":"166","author":"Dorval","year":"2013","journal-title":"Int J Cardiol"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.111.030759","article-title":"Renal insufficiency after contrast media administration trial II (REMEDIAL II) clinical perspective.","volume":"124","author":"Briguori","year":"2011","journal-title":"Circulation"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4244\/EIJV6I9A194","article-title":"Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design.","volume":"6","author":"Briguori","year":"2011","journal-title":"EuroIntervention"},{"key":"R32-12-20210204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1056\/NEJM200007203430304","article-title":"Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine.","volume":"343","author":"Tepel","year":"2000","journal-title":"N Engl J Med"},{"key":"R33-12-20210204","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","article-title":"Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT).","volume":"124","year":"2011","journal-title":"Circulation"},{"key":"R34-12-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.7326\/0003-4819-148-4-200802190-00007","article-title":"Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.","volume":"148","author":"Kelly","year":"2008","journal-title":"Ann Intern Med"},{"key":"R35-12-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00204-010-0626-5","article-title":"Nephrotoxicity of contrast media and protective effects of acetylcysteine.","volume":"85","author":"Briguori","year":"2011","journal-title":"Arch Toxicol"},{"key":"R36-12-20210204","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjcard.2008.08.052","article-title":"Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.","volume":"103","author":"Lev","year":"2009","journal-title":"Am J Cardiol"},{"key":"R37-12-20210204","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ahj.2007.11.042","article-title":"Prevention of radiocontrast medium induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial a randomized controlled study.","volume":"155","author":"Jo","year":"2008","journal-title":"Am Heart J"},{"key":"R38-12-20210204","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2009.09.026","article-title":"Usefulness of atorvastatin (80mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.","volume":"105","author":"Toso","year":"2010","journal-title":"Am J Cardiol"},{"key":"R39-12-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2011.03.001","article-title":"Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN atorvastatin for reduction of myocardial damage during angioplasty - contrast-induced nephropathy trial).","volume":"108","author":"Patti","year":"2011","journal-title":"Am J Cardiol"},{"key":"R40-12-20210204","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.amjcard.2009.04.014","article-title":"Comparison of usefulness of simvastatin 20mg versus 80mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.","volume":"104","author":"Xinwei","year":"2009","journal-title":"Am J Cardiol"},{"key":"R42-12-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1148\/radiology.195.1.7892462","article-title":"Nephrotoxicity from contrast media: attenuation with theophylline.","volume":"195","author":"Katholi","year":"1995","journal-title":"Radiology"},{"key":"R43-12-20210204","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ki.1985.32","article-title":"A role for calcium in radiocontrast-induced reductions in renal hemodynamics.","volume":"27","author":"Bakris","year":"1985","journal-title":"Kidney Int"},{"key":"R44-12-20210204","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4065\/75.12.1275","article-title":"Role of adenosine in contrast media-induced acute renal failure in diabetes mellitus.","volume":"75","author":"Pflueger","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"R45-12-20210204","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1046\/j.1523-1755.2000.00012.x","article-title":"Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.","volume":"57","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"R46-12-20210204","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/ajkd.1998.v31.pm9531185","article-title":"Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy.","volume":"31","author":"Kurnik","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R47-12-20210204","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-1755.1999.00528.x","article-title":"Renal hemodynamics in radiocontrast medium-induced renal dysfunction: a role for dopamine-1 receptors.","volume":"56","author":"Bakris","year":"1999","journal-title":"Kidney Int"},{"key":"R48-12-20210204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0735-1097(03)80973-7","article-title":"A prospective, randomized placebo-controlled multicenter trial evaluating fenoldopam mesylate for the prevention of contrast induced nephropathy: The CONTRAST trial.","volume":"41","author":"Stone","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R49-12-20210204","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2004.04.052","article-title":"N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.","volume":"44","author":"Briguori","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R50-12-20210204","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1161\/CIRCULATIONAHA.109.863159","article-title":"Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.","volume":"120","author":"Spargias","year":"2009","journal-title":"Circulation"},{"key":"R51-12-20210204","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000187090","article-title":"Potential deleterious effect of furosemide in radiocontrast nephropathy.","volume":"62","author":"Weinstein","year":"1992","journal-title":"Nephron"},{"key":"R52-12-20210204","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/978-1-4615-4717-4_42","article-title":"Effect of furosemide or mannitol before injection of a nonionic contrast medium on intrarenal oxygen tension.","volume":"471","author":"Liss","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"R53-12-20210204","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM199411243312104","article-title":"Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.","volume":"331","author":"Solomon","year":"1994","journal-title":"N Engl J Med"},{"key":"R54-12-20210204","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa023204","article-title":"The prevention of radiocontrast-agent-induced nephropathy by hemofiltration.","volume":"349","author":"Marenzi","year":"2003","journal-title":"N Engl J Med"},{"key":"R55-12-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.amjmed.2005.08.002","article-title":"Comparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patients.","volume":"119","author":"Marenzi","year":"2006","journal-title":"Am J Med"},{"key":"R56-12-20210204","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.CCM.0000206287.22318.C3","article-title":"Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.","volume":"34","author":"Klarenbach","year":"2006","journal-title":"Crit Care Med"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e3283653f41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:54:51Z","timestamp":1620953691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201311000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e3283653f41","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}